Tesamorelin is a synthetic growth-hormone-releasing hormone (GHRH) analogue used to treat HIV-associated lipodystrophy by reducing excess abdominal visceral fat.
Administered via daily subcutaneous injection, it works by stimulating the pituitary gland to produce growth hormone.
Common side effects include joint pain, muscle pain, and injection site reactions.
For research use only, not to be used in clinical trials involving humans. Documentation is for information only.
Note:
With this option, we will mix it for you with bacteriostatic water and put it into a disposable pen (no vial received). The pen offers easy and accurate dosing for your research purposes, adjustable from 1 to 60 iu’s. It comes complete with enough alcohol swabs and needles to complete your research, all contained in a case.
If you already have a reusable pen you can also buy this peptide premixed in a cartridge only (see alternate product).